Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2016 - 06/30/2016

Lobbyist name	Joseph Oros
Business name	Boehringer Ingelheim Pharmaceuticals, Inc.
Address	179 Cambridge Drive
City, state, zip code	Glastonbury, CT 06033
Country	US
Agent type	Both
Phone	860-781-2126

Operating Expenses

Date	Type of expense	Amount
1/1/2016-6/30/2016	Advertising expenses	$0.00
1/1/2016-6/30/2016	Photocopies, scans	$0.00
1/1/2016-6/30/2016	Computer equipment, supplies	$0.00
1/1/2016-6/30/2016	Professional dues	$0.00
1/1/2016-6/30/2016	Fax charges	$0.00
1/1/2016-6/30/2016	Internet fees	$0.00
1/1/2016-6/30/2016	Legal fees	$0.00
1/1/2016-6/30/2016	Postage, shipping, delivery	$0.00
1/1/2016-6/30/2016	Office supplies, equipment	$0.00
1/1/2016-6/30/2016	Printing expenses	$0.00
1/1/2016-6/30/2016	Public relations expenses	$0.00
1/1/2016-6/30/2016	Rent	$0.00
1/1/2016-6/30/2016	Office and support staff salaries	$0.00
1/1/2016-6/30/2016	Professional subscriptions	$0.00
1/1/2016-6/30/2016	Taxes	$0.00
1/1/2016-6/30/2016	Telephone, cell phone, handheld	$0.00
1/1/2016-6/30/2016	Utilities (heat, water, electricity)	$0.00
1/1/2016-6/30/2016	Other operating expenses	$0.00
	Total operating expenses	$0.00

Activities, Bill Numbers and Titles

Client: Boehringer Ingelheim Pharmaceuticals, Inc.

Total amount paid by client; lobbyist is unable to report compensation at activity level: $454.49

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1888	An Act Relative to Diabetes Prevention	Support	$0.00	"N/A"
House Bill	3926	An Act relative to substance use, treatment, education and prevention	Neutral	$0.00	"N/A"
House Bill	4450	Conference Committee Report	Neutral	$0.00	"N/A"
Senate Bill	541	An Act concerning out-of-pocket expenses for prescription drug coverage	Neutral	$0.00	"N/A"
Senate Bill	1048	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	"N/A"
Senate Bill	4	Senate Ways and Means Budget Recommendation	Neutral	$0.00	"N/A"
Senate Bill	625	An Act relative to patient access	Neutral	$0.00	"N/A"
House Bill	3817	An Act relative to substance use treatment, education, and prevention	Neutral	$0.00	"N/A"
House Bill	1894	An act relative to pharmacy discounts	Support	$0.00	"N/A"
Senate Bill	1162	An Act relative to chronic care coordination	Support	$0.00	"N/A"
Senate Bill	2022	An Act relative to substance use prevention	Neutral	$0.00	"N/A"
Senate Bill	1040	An Act creating patient choice and education in the dispensing of opiate drugs	Neutral	$0.00	"N/A"
House Bill	4200	House Ways and Means Budget Recommendation	Neutral	$0.00	"N/A"
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.